Core Insights - Burlington Stores reported revenue of $2.71 billion for the quarter ended October 2025, marking a year-over-year increase of 7.1% and an EPS of $1.80 compared to $1.55 a year ago [1] - The reported revenue matched the Zacks Consensus Estimate, resulting in a surprise of -0.02%, while the EPS exceeded expectations by 13.21% [1] Financial Performance Metrics - The company had 1,211 stores at the end of the period, surpassing the four-analyst average estimate of 1,199 [4] - Comparable store sales increased by 1%, which was below the average estimate of 2.4% from four analysts [4] - Net sales of $2.71 billion were above the four-analyst average estimate of $2.69 billion, reflecting a year-over-year change of +7.1% [4] - Other revenue was reported at $4.44 million, slightly below the three-analyst average estimate of $4.7 million, indicating a year-over-year decline of -1.9% [4] Stock Performance - Shares of Burlington Stores have returned +4.9% over the past month, contrasting with a -1.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Earnings Results - Workday, Inc. is set to release its third-quarter earnings results on November 25, with expected earnings of $2.17 per share, an increase from $1.89 per share in the same period last year [1] - The consensus estimate for quarterly revenue is $2.42 billion, compared to $2.16 billion a year earlier [1] Acquisition Announcement - On November 19, Workday announced a definitive agreement to acquire Pipedream, an integration platform that connects over 3,000 business applications [2] - Following the announcement, Workday shares rose by 0.7% to close at $226.64 [2] Analyst Ratings - Citigroup analyst Steven Enders maintained a Neutral rating and increased the price target from $260 to $261 [4] - DA Davidson analyst Gil Luria also maintained a Neutral rating, raising the price target from $225 to $260 [4] - Barclays analyst Raimo Lenschow maintained an Overweight rating and increased the price target from $285 to $288 [4] - TD Cowen analyst J. Derrick Wood maintained a Buy rating but cut the price target from $310 to $290 [4] - Piper Sandler analyst Brent Bracelin upgraded the stock from Underweight to Neutral and raised the price target from $220 to $235 [4]

Core Insights - The S&P 500 closed positively on Friday, indicating a favorable market response to recent earnings reports from major companies [1] - The week saw declines in both the Nasdaq and Dow indices, with decreases of 2.7% [1] Company Performance - Nvidia's earnings report contributed to the positive sentiment in the S&P 500 [1] - Consumer giants Walmart and Target also reported earnings, influencing investor perceptions [1] Market Trends - The overall market experienced volatility, as evidenced by the declines in the Nasdaq and Dow indices during the week [1]

Core Viewpoint - Viking Therapeutics, Inc. reported a wider-than-expected loss in Q3 2025, with shares showing a slight increase of about 1% since the last earnings report, outperforming the S&P 500 [1][3]. Financial Performance - The company reported a Q3 2025 loss of 81 cents per share, which was wider than the Zacks Consensus Estimate of a loss of 70 cents, and a significant increase from a loss of 22 cents per share in the same quarter last year [3]. - Viking Therapeutics has not generated any revenues as it currently has no approved products in its portfolio [3]. - Research and development (R&D) expenses rose to $90 million, compared to $22.8 million in the year-ago period, driven by higher costs related to clinical studies, manufacturing, and increased employee-related expenses [4]. - General and administrative expenses decreased to $8.6 million, down nearly 38% year over year, primarily due to lower legal and patent service costs and stock-related compensation expenses [5]. - As of September 30, 2025, the company had cash, cash equivalents, and short-term investments totaling $715 million, down from $808 million as of June 30, 2025 [5]. Market Reactions - Following the earnings release, there has been a downward trend in estimates revisions, with the consensus estimate shifting down by 19.23% [6]. - The stock currently has a poor Growth Score of F, a Momentum Score of D, and a Value Score of C, placing it in the middle 20% for the value investment strategy [7]. Outlook - Estimates for Viking Therapeutics have been trending downward, indicating a negative shift in market sentiment, with a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the coming months [8].

Core Viewpoint - Lam Research reported strong Q1 fiscal 2026 earnings, surpassing expectations, with significant year-over-year growth in both revenue and earnings per share, despite a recent decline in share price [2][3][12] Financial Performance - Non-GAAP earnings per share for Q1 fiscal 2026 were $1.26, exceeding the Zacks Consensus Estimate by 4.1% and reflecting a 46.5% increase year-over-year [2] - Revenues for the first quarter reached $5.32 billion, surpassing the consensus estimate by 2% and increasing 28% from $4.17 billion in the same quarter last year [3] Revenue Breakdown - Systems revenues accounted for $3.55 billion, representing 66.6% of total revenues, up 3% from the previous quarter and 48% year-over-year [4] - Customer Support Business Group revenues were $1.77 billion, making up 33.4% of total revenues, with a 2.5% rise from the previous quarter and a slight 0.1% increase year-over-year [5] Operating Metrics - Non-GAAP gross margin improved to 50.6%, up 30 basis points from the previous quarter, while non-GAAP operating expenses rose to $831.92 million, a 1.2% increase [6] - The non-GAAP operating margin improved to 35%, reflecting a 60 basis points sequential increase [6] Balance Sheet and Cash Flow - As of September 28, 2025, Lam Research held $6.69 billion in cash and cash equivalents, an increase from $6.39 billion in the prior quarter [7] - Cash flow from operating activities decreased to $1.78 billion, down from $2.55 billion in the previous quarter, with dividends paid totaling $291.9 million and share repurchases amounting to $975.8 million [7] Guidance and Outlook - For Q2 fiscal 2026, Lam Research projects revenues of $5.2 billion (+/- $300 million), with a non-GAAP gross margin of 48.5% (+/-1%) and non-GAAP earnings per share of $1.15 (+/- $0.10) [8] - Recent estimate revisions have shown a 10.53% upward trend, indicating positive sentiment among analysts [10] - Lam Research holds a Zacks Rank 2 (Buy), suggesting expectations for above-average returns in the coming months [12]

Company Overview - Zoom Communications is valued at approximately $24 billion and generated $4.8 billion in revenue over the past year, with an operating profit of $971 million and a net income of $1.2 billion [2]. Earnings Performance - Historically, Zoom has underperformed market expectations on earnings day, often providing conservative guidance and experiencing slow enterprise growth or muted customer expansion [2]. - There have been 19 documented earnings data points over the last five years, with only 5 positive one-day (1D) returns, resulting in a positive return rate of approximately 26%. This rate increases to 40% when considering the last 3 years [9]. Trading Strategies - Traders can prepare for Zoom's earnings by either gauging historical probabilities and positioning themselves before the announcement or analyzing the relationship between immediate and medium-term returns after earnings [3]. - A less risky strategy involves assessing the correlation between short-term and medium-term returns following earnings, allowing traders to position themselves accordingly based on positive 1D returns [6]. Peer Comparison - The performance of peers can influence post-earnings stock reactions, with market expectations potentially setting in before Zoom's earnings announcements [7].

Core Insights - Walmart Inc. reported stronger-than-expected third-quarter results, leading to a more than 5% increase in its share price intra-day [1] - The company is experiencing less tariff-related pressure than initially anticipated earlier in the year [1] Financial Performance - Adjusted earnings per share were $0.62, exceeding analyst expectations of $0.60 [2] - Revenue reached $179.5 billion, surpassing the consensus estimate of $177.45 billion, marking a year-over-year increase of 5.8% or 6.0% in constant currency [2] - Global eCommerce sales increased by 27%, highlighting one of the company's fastest-growing segments [2] Sales and Revenue Growth - Comparable sales in Walmart U.S. rose by 4.5%, showing broad-based strength across various categories [3] - Global advertising revenues surged by 53%, with contributions from VIZIO, while Walmart Connect in the U.S. grew by 33% [3] - Membership income saw a significant increase of 16.7% [3] Future Outlook - Walmart raised its fiscal 2026 outlook, projecting net sales growth of 4.8% to 5.1% and adjusted operating income growth of 4.8% to 5.5%, both on a constant-currency basis [4] - Adjusted EPS is now expected to be between $2.58 and $2.63, compared to the previous guidance of $2.52 to $2.62 [4]

Core Insights - Danaher Corporation's third-quarter 2025 adjusted earnings of $1.89 per share exceeded the Zacks Consensus Estimate of $1.71, marking a 10.5% year-over-year increase [3] - The company reported net sales of $6.05 billion, surpassing the consensus estimate of $6.00 billion, with a year-over-year growth of 4.5% [3] - The overall core sales increased by 3% year over year, with foreign-currency translations contributing positively by 1.5% [4] Segment Performance - Life Sciences segment revenues reached $1.79 billion, a 0.5% increase year over year, although core sales decreased by 1% [5] - Diagnostics segment revenues totaled $2.46 billion, up 4% year over year, with core sales increasing by 3.5% [6] - Biotechnology segment revenues were $1.80 billion, reflecting a 9% year-over-year increase, with core sales rising by 6.5% [7] Margin and Profitability - Danaher's cost of sales rose by 5.5% year over year to $2.53 billion, while gross profit increased by 3.6% to $3.52 billion, resulting in a gross margin of 58.2% [8] - Operating profit surged by 20.5% year over year to $1.15 billion, with the operating margin expanding to 19.1% from 16.5% [9] Balance Sheet and Cash Flow - At the end of the third quarter, Danaher had cash and equivalents of $1.53 billion, down from $2.08 billion at the end of 2024, while long-term debt increased to $16.8 billion [10] - The company generated net cash of $4.30 billion from operating activities in the first nine months of 2025, a decrease from $4.67 billion in the previous year [11] Future Outlook - For the fourth quarter, Danaher anticipates adjusted core sales from continuing operations to grow in the low single digits year over year, with adjusted earnings expected to be between $7.70 and $7.80 per share [12] - Estimates for the stock have trended downward, with a consensus estimate shift of -9.79% over the past month [13] Investment Scores - Danaher currently holds a subpar Growth Score of D and a Momentum Score of F, with an aggregate VGM Score of F, indicating it is in the bottom 40% for value investors [14]

Core Viewpoint - Lockheed Martin's recent earnings report shows a positive trend in earnings and sales, despite a slight decline in share price over the past month, leading to questions about future performance leading up to the next earnings release [1][2]. Financial Performance - Lockheed Martin reported Q3 2025 adjusted earnings of $6.95 per share, exceeding the Zacks Consensus Estimate of $6.33 by 9.8%, and up 2.2% from $6.80 in the same quarter last year [2]. - Net sales reached $18.61 billion, surpassing the Zacks Consensus Estimate of $18.56 billion by 0.3%, and increased 8.8% from $17.10 billion year-over-year [3]. Operational Highlights - The backlog as of September 28, 2025, was $179.07 billion, up from $176.04 billion at the end of 2024, with significant contributions from various segments: Aeronautics ($47.51 billion), Missiles and Fire Control ($45.91 billion), Rotary and Mission Systems ($47.27 billion), and Space ($38.39 billion) [4]. - Segment performance included: - Aeronautics: Sales increased 11.9% to $7.26 billion, driven by the F-35 program, with an operating profit of $682 million [5]. - Missiles and Fire Control: Sales improved 14.1% to $3.62 billion, with an operating profit of $510 million [6]. - Space: Sales rose 9.1% to $3.36 billion, with an operating profit of $331 million [7]. - Rotary and Mission Systems: Revenues increased 0.1% to $4.37 billion, with an operating profit of $506 million [7]. Financial Condition - Cash and cash equivalents totaled $3.47 billion as of September 28, 2025, up from $2.48 billion at the end of 2024, while cash from operating activities was $5.34 billion compared to $5.95 billion a year ago [8]. - Long-term debt decreased to $20.52 billion from $19.63 billion as of December 31, 2024 [8]. Guidance and Estimates - Lockheed expects 2025 sales in the range of $74.25-$74.75 billion, slightly narrower than the previous estimate, with the Zacks Consensus Estimate at $74.20 billion [9]. - Adjusted EPS guidance has been raised to a range of $22.15-$22.35, compared to the earlier guidance of $21.70-$22.00, with the consensus estimate at $21.86 [10]. - The company anticipates generating approximately $8.50 billion in cash from operations and a free cash flow of about $6.60 billion [11]. Market Sentiment - Estimates for Lockheed Martin have trended downward over the past month, indicating a potential shift in market sentiment [12]. - The company holds a VGM Score of B, with a Growth Score of B, a Momentum Score of F, and a Value Score of B, placing it in the second quintile for value investors [13]. - Lockheed has a Zacks Rank 3 (Hold), suggesting an expectation of an in-line return from the stock in the coming months [14].

Core Insights - Walmart reported strong quarterly results, exceeding Wall Street expectations and raising its full-year outlook for sales and adjusted EPS [1][8] Financial Performance - In Q3 of fiscal year 2026, Walmart earned an adjusted $0.62 per share, surpassing analyst consensus by 2 cents [2] - Revenue increased by 5.8% year-over-year to $179.5 billion, which is $2 billion above analyst forecasts [2] - Comparable sales rose by 4.2%, slightly above analyst estimates, while e-commerce sales surged by 27% and advertising revenue grew by 53% [2] Outlook - Walmart raised its full-year revenue growth forecast to 4.8% to 5.1%, up from a previous range of 3.75% to 4.75% [3] - Adjusted EPS is now projected to be between $2.58 and $2.63, a slight increase from the prior range of $2.52 to $2.62 [3] Market Reaction - Following the earnings report, Walmart shares rose by 6%, recovering from a late-October decline, and have gained nearly 15% since the beginning of the year [4] Strategic Moves - Walmart announced a transition of its stock listing from the New York Stock Exchange to Nasdaq, maintaining its "WMT" ticker, with the move expected by December 9 [7] - This strategic shift aligns with Walmart's long-term tech-powered approach, as stated by CFO John David Rainey [7] Leadership Change - CEO Doug McMillon will step down at the end of January 2024, with John Furner, the current CEO of Walmart U.S., set to take over [6] Industry Insights - As the largest retailer in the U.S., Walmart's performance offers insights into consumer spending trends, indicating that higher-income consumers are increasingly shopping at its stores [5] - Analysts from JPMorgan noted that despite some concerns, there has not been significant change in Walmart's performance trends over recent quarters [5]